Plantar warts usually go away on their own within 2 years, but a variety of treatments may make them disappear faster. You can prevent plantar warts by protecting your feet in public places.

Medically reviewed by Casey Gallagher, MD Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the ...

The ideal treatment for palmoplantar warts has yet to be devised. Warts can disappear spontaneously. The larger their size and the longer they have been present, the less likely warts are to ...

For patients with moderate to severe palmoplantar psoriasis, response to the monoclonal antibody ixekizumab is quick, and the efficacy persisted out to 60 weeks, according to investigators.

Soles affected by palmoplantar keratoderma showing immense and well circumscribed, waxy yellow thickening of the skin surrounded by prominent erythematous border and fissures/cracks.

BOSTON — A phase 2 trial found Japanese patients with palmoplantar pustulosis treated with apremilast showed significant and early improvement, according to a poster presented at the ...

Patients with scalp and palmoplantar psoriasis treated with bimekizumab had a high rate of clearance maintained through 4 years of treatment, according to a poster presented at the European ...

BALLERUP, Denmark, June 03, 2025--LEO Pharma Initiates Phase 2a DELTA NEXT Trial of Delgocitinib Cream in Adults with Mild to Severe Palmoplantar Pustulosis (PPP) ...

Comorbidities associated with psoriasisꟷdiabetes, cardiovascular disease, and mood disorderꟷwere found to be prevalent in patients with plaque palmoplantar psoriasis.

DelveInsight has recently released a series of epidemiology-based market reports on rare skin diseases including Pemphigus Vulgaris, Epidermolysis Bullosa, Palmoplantar Pustulosis, and Prurigo ...

--Sol-Gel Technologies, Ltd. today announced the initiation of a Phase 1 proof of concept clinical study of SGT-210, its novel, topical, epidermal growth factor receptor inhibitor in patients with ...

MoonLake Immunotherapeutics Initiates New Trials for Sonelokimab in Adolescent Hidradenitis Suppurativa, Palmoplantar Pustulosis, and Axial Spondyloarthritis ...